Page last updated: 2024-09-05

hoe 166 and Malignant Melanoma

hoe 166 has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, YH; Lee, JD; Lee, MG; Lee, TH; Shin, JL; Yang, WI	1

Other Studies

1 other study(ies) available for hoe 166 and Malignant Melanoma

Article	Year
Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma. Immunology letters, 2006, Jul-15, Volume: 106, Issue:1 Topics: Animals; Antigens, CD; Cell Line, Tumor; Cell- and Tissue-Based Therapy; Dendritic Cells; Female; Immunotherapy; Injections; Killer Cells, Natural; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Piperidines; Radioisotopes; Survival Rate; T-Lymphocytes, Cytotoxic; Thiazines	2006

Article

Year

Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma.

Immunology letters, 2006, Jul-15, Volume: 106, Issue:1

Topics: Animals; Antigens, CD; Cell Line, Tumor; Cell- and Tissue-Based Therapy; Dendritic Cells; Female; Immunotherapy; Injections; Killer Cells, Natural; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Piperidines; Radioisotopes; Survival Rate; T-Lymphocytes, Cytotoxic; Thiazines

2006